Abeona Therapeutics (ABEO) Seen 'Aggressively' Pursuing a Sale Following Board and CEO Departures - Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Kristen Kluska said following the significant board departures at Abeona Therapeutics (NASDAQ: ABEO) they expect the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
